Brand-Name Zepbound: The Full List Price
Zepbound (tirzepatide injection) is manufactured by Eli Lilly and approved for weight loss. The brand-name version carries a high list price: from $500 to $1,200+ per monthly injection depending on your prescribed dose (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg). This is the price pharmacies charge before insurance or discounts are applied. Most patients paying out-of-pocket never see this list price because insurance, manufacturer programs, or coupons intervene.
The high list price reflects several factors: brand premium, research and development costs, FDA approval expenses, and limited competition (tirzepatide had no generic equivalent as of early 2026). Eli Lilly sets these prices knowing that most insured patients will pay copays instead, but uninsured patients are exposed to the full cost. This dynamic has driven many patients toward compounded alternatives.
- Dose 2.5mg: approximately $500-700/month
- Dose 5mg-7.5mg: approximately $700-900/month
- Dose 10mg-15mg: approximately $900-1,200+/month
- Prices vary by pharmacy and manufacturer promotions